Covered recipient · General Payments record
ALEXANDER E PERL
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$171,970.39
- Reported across 175 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,862.75 | 2 |
| Food and Beverage | $876.31 | 11 |
| Travel and Lodging | $759.49 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $3,948.54 | 6 |
| Daiichi Sankyo Inc. | $3,447.51 | 6 |
| ABBVIE INC. | $51.99 | 1 |
| Genentech USA, Inc. | $50.51 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $51.99 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105241582 | CMS |
| Astellas Pharma US Inc | $117.50 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139327732 | CMS |
| Astellas Pharma US Inc | $3,444.00 | 05/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139385642 | CMS |
| Astellas Pharma US Inc | $13.24 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139453992 | CMS |
| Astellas Pharma US Inc | $75.66 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139371981 | CMS |
| Astellas Pharma US Inc | $151.34 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139392038 | CMS |
| Astellas Pharma US Inc | $146.80 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139390536 | CMS |
| Daiichi Sankyo Inc. | $15.12 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089468854 | CMS |
| Daiichi Sankyo Inc. | $2,418.75 | 07/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089468848 | CMS |
| Daiichi Sankyo Inc. | $291.64 | 08/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089468850 | CMS |
| Daiichi Sankyo Inc. | $124.15 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089468846 | CMS |
| Daiichi Sankyo Inc. | $467.85 | 09/27/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089468844 | CMS |
| Daiichi Sankyo Inc. | $130.00 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089468852 | CMS |
| Genentech USA, Inc. | $27.18 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132973813 | CMS |
| Genentech USA, Inc. | $23.33 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132973815 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.